Tested Applications
| Positive IF/ICC detected in | HeLa cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
19674-1-AP targets COL4A4 in WB, IHC, IF/ICC, CoIP, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human, mouse, rat, duck |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
Peptide Predict reactive species |
| Full Name | collagen, type IV, alpha 4 |
| Calculated Molecular Weight | 164 kDa |
| GenBank Accession Number | NM_000092 |
| Gene Symbol | COL4A4 |
| Gene ID (NCBI) | 1286 |
| RRID | AB_2878595 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P53420 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
COL4A4 belongs to the type IV collagen family. COL4A4 is the major structural component of glomerular basement membranes (GBM), forming a 'chicken-wire' meshwork together with laminins, proteoglycans and entactin/nidogen. Defects in COL4A4 are a cause of Alport syndrome autosomal recessive (APSAR). Defects in COL4A4 are a cause of benign familial hematuria (BFH). This antibody is specific to COL4A4.
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for COL4A4 antibody 19674-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The COL4A4 Polyclonal antibody (catalog 19674-1-AP) has 24 total citations across journals including Cell, Cell Stem Cell, Cell Reports Medicine, Bioactive Materials, Journal of Ethnopharmacology, Biochemical Pharmacology, European Journal of Pharmacology, iScience, Scientific Reports, and Acta Diabetologica. Research fields span cancer biology (medulloblastoma, colorectal cancer, brain metastasis), kidney disease and diabetic nephropathy, tissue fibrosis (liver, renal, peritoneal), organoid/stem-cell development, metabolism and obesity, plus neurobiology and glaucoma genetics. Applications include WB, IF, IHC, and CoIP across human, mouse, rat, and duck samples.
| Species | Application | Title |
|---|---|---|
Cell Early rhombic lip Protogenin+ve stem cells in a human-specific neurovascular niche initiate and maintain group 3 medulloblastoma | ||
Bioact Mater Bioengineering an improved three-dimensional vascularized co-culture model for studying Neuron-Microglia interactions. | ||
Cell Stem Cell Enhanced viability and functional maturity of iPSC-derived islet organoids by collagen-VI-enriched ECM scaffolds | ||
Cell Rep Med Targeting the HSP47-collagen axis inhibits brain metastasis by reversing M2 microglial polarization and restoring anti-tumor immunity | ||
Biomed Pharmacother Glucosamine alleviates liver fibrosis through modulation of sinusoidal blood flow and hepatic immune responses | ||
Chin Med Fat-targeted small molecule alleviates abnormal adipose tissue remodeling in obesity via SIRT3-driven mitophagy and inflammasome inhibition. |

